Lucid Diagnostics Inc.(NasdaqGM:LUCD) dropped from Russell 3000 Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9297 USD | -2.14% | +38.74% | -34.06% |
27/03 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
26/03 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.06% | 47.3M | |
+73.37% | 12.38B | |
-17.09% | 7.99B | |
+16.88% | 7.21B | |
+3.57% | 5.79B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4.17B | |
-35.26% | 2.44B | |
+3.09% | 2.03B |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- Lucid Diagnostics Inc.(NasdaqGM: LUCD) dropped from Russell 3000 Value Index